baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

Pharming Group NV/ NL0010391025 /

2024-04-23 5:29:47 PM	Chg. +0.01	Volume	Bid5:30:00 PM	Ask5:30:00 PM	High	Low
0.91EUR	+1.06%	435,469 Turnover: 264,274.85	-Bid Size: -	-Ask Size: -	0.92	0.91

GlobeNewswire 04-08 Pharming announces completion of enrollment in pediatric clinical trial of leniolisib

GlobeNewswire 04-03 Pharming Group to participate in April investor conferences

GlobeNewswire 03-14 Pharming Group reports fourth quarter and full year 2023 financial results

GlobeNewswire 02-29 Pharming Group to report fourth quarter and full year 2023 financial results on March 14

GlobeNewswire 02-08 Pharming Group to participate in February investor conferences

GlobeNewswire 01-08 Pharming Group announces updated full year 2023 guidance and Joenja® U.S. launch update

GlobeNewswire 2023-12-13 Pharming Group announces development plans for leniolisib for additional primary immunodeficiencies ...

GlobeNewswire 2023-11-21 Pharming announces first patient dosed in pediatric clinical trial for children aged 1 to 6 years fo...

GlobeNewswire 2023-11-13 Orchard Therapeutics Reports Third Quarter 2023 Financial Results and Highlights Recent Business Acc...

GlobeNewswire 2023-11-01 Pharming Group to participate in November investor conferences

GlobeNewswire 2023-10-26 Pharming Group reports third quarter 2023 financial results

GlobeNewswire 2023-10-12 Pharming Group to report third quarter 2023 financial results on October 26

GlobeNewswire 2023-09-25 Pharming Group reports on results of the 2023 Extraordinary General Meeting of Shareholders

GlobeNewswire 2022-01-10 Orchard Therapeutics Announces Recent Commercial and Regulatory Progress for Late-stage HSC Gene The...

GlobeNewswire 2021-11-04 Orchard Therapeutics Reports Third Quarter 2021 Financial Results and Highlights Recent Business Upd...

GlobeNewswire 2021-08-04 Orchard Therapeutics Reports Second Quarter 2021 Financial Results and Highlights Recent Business Up...

GlobeNewswire 2021-07-29 Oncorus Expands its Board with Appointment of Barbara Yanni

GlobeNewswire 2021-07-01 Orchard Therapeutics and Pharming Group Announce Collaboration to Develop and Commercialize ex vivo ...

GlobeNewswire 2021-01-20 Longboard Pharmaceuticals Appoints Phillip Schneider and Paul Sekhri to Board of Directors

GlobeNewswire 2019-01-09 Global Hereditary Hematological Disorders Drug Development Pipeline Review 2018

GlobeNewswire 2018-06-08 Fabry's Disease Pipeline Analysis 2018 - Focusing on Clinical Trials and Results, Drug Profiling, Pa...

GlobeNewswire 2018-05-29 Asia-Pacific Hereditary Angioedema (HAE) Therapeutics Markets 2018-2023: Marketed Products, Pipeline...

GlobeNewswire 2014-03-06 Pharming Reports On Preliminary Financial Results 2013

GlobeNewswire 2014-02-24 PHARMING AND SALIX ANNOUNCE EXTENSION OF PDUFA ACTION DATE FOR RUCONEST®

GlobeNewswire 2013-11-08 PHARMING AND SANTARUS ANNOUNCE NEW DATA FROM OPEN-LABEL REPEAT TREATMENT STUDY WITH RUCONEST

Pharming Group NV/ NL0010391025 /

If you wish to receive reply to your feedback, please provide your email address.